Use of an Off-the-Shelf Exergame as an In-Bed Gamified Rehabilitation Intervention for Severely Deconditioned Inpatients: A Feasibility Study
Feasibility of Exergame-Based Rehabilitation in Patients With Limited Mobility
1 other identifier
interventional
26
1 country
1
Brief Summary
- 1.Study Title:
- 2.Purpose of the Study:
- 3.Study Participants:
- 4.Research Methodology:
- 5.Safety and Efficacy Monitoring: Participants' physical function (e.g., strength, mobility) is tracked throughout the study. Patients are continuously monitored for any discomfort or adverse events during exercise sessions. Motor responses are closely observed to ensure utmost safety.
- 6.Study Duration:
- 7.Expected Results:
- 8.Safety Considerations:
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 16, 2024
CompletedFirst Submitted
Initial submission to the registry
April 20, 2025
CompletedFirst Posted
Study publicly available on registry
April 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2025
CompletedResults Posted
Study results publicly available
June 9, 2026
CompletedJune 9, 2026
May 1, 2026
12 months
April 20, 2025
March 19, 2026
May 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Session Completion Rate
Feasibility and adherence were assessed by the number of completed and discontinued exercise movements and completed sessions during the intervention period. A session was considered interrupted if terminated before completing the planned exercise set. Completed sessions rate: percentage of 10 planned sessions finished per each participants Outcomes are percentages (0-100); higher values indicate better adherence
Baseline (at enrollment) and end of intervention (after completion of 10 sessions, up to 2 weeks)
Exercise Movement Completion Rate
Feasibility and adherence were assessed by the number of completed and discontinued exercise movements during the intervention period. An exercise movement was considered discontinued if the participant stopped or was unable to complete the specific repetitions or prescribed movements within a session. Exercise movement completion rate is the percentage of prescribed movements successfully finished per each participant. Outcomes are percentages (0-100); higher values indicate better adherence.
Baseline (at enrollment) and end of intervention (after completion of 10 sessions, up to 2 weeks)
Secondary Outcomes (4)
Net Exercise Time
Baseline (at enrollment), Week 1 (midpoint after 1 week of intervention), and Week 2 (end of intervention after completion of 10 sessions)
Medical Research Council Sum Score (MRC-SS)
Baseline (at enrollment), Week 1 (midpoint after 1 week of intervention), and Week 2 (end of intervention after completion of 10 sessions)
Functional Ambulatory Category (FAC)
Baseline (at enrollment), Week 1 (midpoint after 1 week of intervention), and Week 2 (end of intervention after completion of 10 sessions)
ICU Mobility Scale
Baseline (at enrollment), Week 1 (midpoint after 1 week of intervention), and Week 2 (end of intervention after completion of 10 sessions)
Other Outcomes (13)
Hand Grip Strength Test
Baseline (at enrollment), Week 1 (midpoint after 1 week of intervention), and Week 2 (end of intervention after completion of 10 sessions)
Knee Extensor Test
Baseline (at enrollment), Week 1 (midpoint after 1 week of intervention), and Week 2 (end of intervention after completion of 10 sessions)
EuroQol 5-Dimension 5-level(EQ-5D-5L) Index Value
Baseline (at enrollment), Week 1 (midpoint after 1 week of intervention), and Week 2 (end of intervention after completion of 10 sessions)
- +10 more other outcomes
Study Arms (1)
Intervetional
EXPERIMENTALSince study includes single arm, all participants will receive 2 weeks of exergaming rehabilitation intervetion
Interventions
Unambulatory patients after critical care will receive 2 weeks of exergaming rehabilitation(Nintendo Ring Fit Adventure™) in addition to usual physical therapy in bed setting.
Eligibility Criteria
You may qualify if:
- Organ transplant recipients. Aged 18 years or older who have provided written informed consent. Patients who required critical care. Patients with restricted mobility, defined as an FAC score of 3 or less (unable to ambulate independently).
You may not qualify if:
- Inability to follow instructions due to cognitive impairment or sedation. Hemodynamic instability precluding rehabilitation. Severe musculoskeletal limitations (e.g., unstable fractures, recent amputations) preventing exercise participation.
- Significant sensory impairments (e.g., severe hearing or visual loss) hindering interaction with the exergaming system.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asan Medical Center
Seoul, Seoul, 05505, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
This study has several limitations. As a single-arm feasibility study without a control group, the definitive clinical efficacy of the intervention cannot be determined. Additionally, the small sample size (n=20) limits statistical power. Finally, because the study focused on a specific population (post-transplant inpatients with severe deconditioning), the findings may not be fully generalizable to other patient groups.
Results Point of Contact
- Title
- Won Kim, MD, PhD
- Organization
- Asan Medical Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 20, 2025
First Posted
April 22, 2025
Study Start
October 16, 2024
Primary Completion
September 30, 2025
Study Completion
October 31, 2025
Last Updated
June 9, 2026
Results First Posted
June 9, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
All individual patient data (IPD) used in this study will be handled in compliance with domestic privacy protection laws and relevant regulations. The privacy of study participants will be strictly safeguarded, and their personal information will not be used for purposes other than the study. When sharing data, only de-identified data that has been approved by the researchers after adequate request will be provided, and privacy protection and security will be prioritized throughout the process.